 |
|
Kisspeptin and DLK1 levels for monitoring treatment of girls with central precocious puberty
Witchuwan Onsoi, Nattakarn Numsriskulrat, Suphab Aroonparkmongkol, Vichit Supornsilchai, Khomsak Srilanchakon
Clin Exp Pediatr. 2024;67(6):296-302. Published online 2024 May 21 DOI: https://doi.org/10.3345/cep.2023.01361
|
|
Citations to this article as recorded by
 Serum DLK1 During Minipuberty and Pubertal Transition in Healthy Girls and in Girls With Precocious Puberty
Lea Vilmann, Kaspar Sørensen, Alexander S Busch, Marie L Ljubicic, Emmie N Upners, Margit B Fischer, Trine H Johannsen, Stine A Holmboe, Anders Juul, Casper P Hagen
The Journal of Clinical Endocrinology & Metabolism.2025; 110(6): 1570. CrossRef A New Hope for Woman with Vasomotor Symptoms: Neurokinin B Antagonists
Blazej Meczekalski, Anna Kostrzak, Christian Unogu, Stefania Bochynska, Marzena Maciejewska-Jeske, Gregory Bala, Anna Szeliga
Journal of Clinical Medicine.2025; 14(5): 1438. CrossRef The hippo pathway: a molecular bridge between environmental cues and pace of life
Ehsan Pashay Ahi, Bineet Panda, Craig R. Primmer
BMC Ecology and Evolution.2025;[Epub] CrossRef Serum phoenixin levels in girls with central precocious puberty and premature thelarche
Yujie Qin, Hongyang Deng, Lujie Liu, Meng Li, Jiong Yang, Chenglin Zhang, Jing Zhou, Yanfeng Xiao
Endocrine.2024; 87(2): 857. CrossRef
|